United States· US:68382-110_b9165827-6509-4d3c-813a-547929b720da
Bromocriptine mesylate
A bromocriptine product containing bromocriptine mesylate, registered in United States by Zydus Pharmaceuticals USA Inc.. The same ATC class is registered in 8 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Bromocriptine is registered in 8 of 19 countries.
Countries holding a registration under ATC N04BC01 (bromocriptine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Bromocriptine · ATC N04BC01
8 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bromocriptine costs, country by country.
Normalised to the WHO defined daily dose (40 mg), so markets compare like for like.
- United States: $32.93 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Bromocriptine · price per daily dose (40 mg)
USD · FX 28 Sept 2026
- US United States$32.93 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BROMOCRIPTINE MESYLATE
- Manufacturer
- Zydus Pharmaceuticals USA Inc.
- Country
- United States (US)
- ATC code
- N04BC01
- ATC class
- Bromocriptine
- Defined daily dose
- 40 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 26, 2026
Packs & prices · 4
- ndc116838211001100 CAPSULE in 1 BOTTLE (68382-110-01)
- ndc11683821100630 CAPSULE in 1 BOTTLE (68382-110-06)
- ndc1168382-110-01
- ndc1168382-110-06
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
92 interactions on record for bromocriptine.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bromocriptine · interactions on record
92 records
- 3 severe
- 87 moderate
- 2 minor
Most severe, free to view
- IsomethepteneA03AX10severe
- LorcaserinA08AA11severe
- PhenylpropanolaminA08AA13severe
- LansoprazoleA02BC03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bromocriptine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandParlodelParanova Oy
- SpainPARLODEL 5 mg CAPSULASExeltis Healthcare S.L.
- BelgiumParlodel 5 mgExeltis Germany
- FrancePARLODEL 5 mg, géluleEXELTIS SANTE
- United KingdomParlodel 5mg capsulesViatris UK Healthcare Ltd
- CanadaBROMOCRIPTINEAA PHARMA INC
- CzechiaMEDOCRIPTINEMedochemie Ltd., Limassol
- SwedenParlodel 2,5 mg TablettEbb Medical AB
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Belgium · Parlodel
- Bulgaria · Бромокриптин Медокеми
- Cyprus · Medocriptine, Pirodal
- Czechia · Medocriptine
- Germany · Pravidel
- Estonia · Bromocriptin Richter
- Spain · Parlodel
- France · Parlodel
- United Kingdom (Northern Ireland) · Bromocriptine, Bromocriptine Brown & Burk Uk
- Hungary · Bromocriptin Richter
- Italy · Parlodel
- Lithuania · Bromocriptin Richter
- Luxembourg · Pravidel
- Latvia · Bromocriptin Richter
- Malta · Medocriptine
- Netherlands · Parlodel
- Norway · Parlodel
- Poland · Bromocorn
- Portugal · Bromocriptina Generis, Parlodel
- Romania · Brocriptin
- Sweden · Pravidel
- Slovakia · Medocriptine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d0384195-7cf7-4d26-8a78-d903bda565cf GET /v1/drugs/d0384195-7cf7-4d26-8a78-d903bda565cf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "5",
"substance": "BROMOCRIPTINE MESYLATE",
"productndc": "68382-110",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA078899",
"marketing_category": "ANDA"
}See everything about bromocriptine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.